Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Other Non-Current Assets (2019 - 2026)

Orthopediatrics has reported Other Non-Current Assets over the past 5 years, most recently at $15.9 million for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 23.95% year-over-year to $15.9 million; the TTM value through Mar 2026 reached $15.9 million, up 23.95%, while the annual FY2025 figure was $15.7 million, 50.48% up from the prior year.
  • Other Non-Current Assets for Q1 2026 was $15.9 million at Orthopediatrics, up from $15.7 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $15.9 million in Q1 2026 and troughed at $614000.0 in Q2 2023.
  • A 4-year average of $8.9 million and a median of $10.3 million in 2024 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: soared 1551.53% in 2024 and later rose 23.95% in 2026.
  • Year by year, Other Non-Current Assets stood at $2.9 million in 2023, then soared by 254.32% to $10.4 million in 2024, then soared by 50.48% to $15.7 million in 2025, then increased by 1.31% to $15.9 million in 2026.
  • Business Quant data shows Other Non-Current Assets for KIDS at $15.9 million in Q1 2026, $15.7 million in Q4 2025, and $13.6 million in Q3 2025.